Store
GS2 · Health

Draft rule ends duplicate viral tests on blood products

1 min readHealth
Battle IAS current affairs title card: Draft rule ends duplicate viral tests on blood products (GS2 · Health, 11 March 2026)

What happened

  • MoHFW issued draft GSR 164(E) of 9 March 2026 amending the Drugs Rules, 1945 to remove duplicate viral testing of blood products [PIB].

Background

  • It aligns testing with global pharmacopoeial standards [PIB].

Why it matters

  • Fewer duplicate tests can cut cost without lowering safety, if standards hold.

How to use this in Mains

GS-II Issues relating to development and management of health

  1. As per PIB (2026-03-11): moHFW issued draft GSR 164(E) of 9 March 2026 amending the Drugs Rules, 1945 to remove duplicate viral testing of blood products.
  2. Fewer duplicate tests can cut cost without lowering safety, if standards hold.
Quotable data point

MoHFW issued draft GSR 164(E) of 9 March 2026 amending the Drugs Rules, 1945 to remove duplicate viral testing of blood products.

PIB: Drugs Rules draft, 11 Mar 2026

Exam angle

UPSC

Prelims: Drugs Rules 1945.

Practice MCQs

Original practice questions (not PYQs).

Practice · UPSC

Draft amendment is to the

Answer (a) & explanation

PIB.

Go deeper

ExplainerOne Health Approach: Why Human, Animal and Environmental Health Are Linked, Zoonotic Diseases, the Global Quadripartite and India’s National One Health Mission (UPSC Notes + PYQs)ExplainerAntimicrobial Resistance (AMR): How Superbugs Arise, the Global and Indian Burden, Causes in Hospitals, Farms and the Environment, and India’s National Action Plan 2.0 (UPSC Notes + PYQs)

Official source: PIB: Drugs Rules draft, 11 Mar 2026

facts from cited sources only; faculty review pending